About IntelliCyt
IntelliCyt is a company based in Albuquerque (United States) founded in 2006 was acquired by Sartorius in June 2016. IntelliCyt has raised $13.82 million across 4 funding rounds from investors including Sartorius, Oxford Finance and New Mexico Community Capital. IntelliCyt offers products and services including Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System. IntelliCyt operates in a competitive market with competitors including Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.
- Headquarter Albuquerque, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sartorius Ag
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntelliCyt
IntelliCyt offers a comprehensive portfolio of products and services, including Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System.
Device for biolayer interferometry in protein analysis
Multi-parallel system for cell culture in research
Tool for sterility testing in pharmaceuticals
Instrument for cell-based assays in screening
Funding Insights of IntelliCyt
IntelliCyt has successfully raised a total of $13.82M across 4 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $2 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IntelliCyt
IntelliCyt has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Sartorius, Oxford Finance and New Mexico Community Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Health-focused venture capital investments are made in US sectors.
|
Locked | Locked | Locked |
Investor details for IntelliCyt
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntelliCyt
Investment portfolio details for IntelliCyt
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IntelliCyt
Detailed financials for IntelliCyt
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intellicyt Comparisons
Peer comparison for IntelliCyt
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IntelliCyt
IntelliCyt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
IVD platforms are developed to detect and target cancer cells.
|
|
| Locked | Locked | Locked |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
|
| Locked | Locked | Locked |
Instrumentation for cell and protein analysis is developed and marketed.
|
Detailed competitors of IntelliCyt
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intellicyt
Complete news archive for IntelliCyt
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntelliCyt
IntelliCyt was founded in 2006 and raised its 1st funding round 7 years after it was founded.
IntelliCyt is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
IntelliCyt is a funded company, having raised a total of $13.82M across 4 funding rounds to date.
Screening solutions for researchers and biopharmaceutical companies are developed by IntelliCyt, founded in 2006 in Albuquerque, United States. The iQue flow cytometer platform is utilized for cell-based and bead-based assays, with associated software and reagents also supplied. Operations focus on the biotechnology sector, supporting high-throughput screening in drug discovery and research applications.
IntelliCyt's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
IntelliCyt offers Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System.
IntelliCyt has 6 investors. Key investors include Sartorius, Oxford Finance, New Mexico Community Capital, Arboretum Ventures, and Prolog Ventures.